DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC OUTCOMES IN CHILDREN AGED 1 TO <12 YEARS WITH EOSINOPHILIC ESOPHAGITIS (EOE): 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL

Authors
Category Primary study
ConferenceGastroenterology
Year 2024
This article has no abstract
Epistemonikos ID: 1e7a7e43737c78984a9565905e06dd94ca084b9d
First added on: Apr 29, 2026